TrialInvestigational new drugs2011

Phase II study of second line gemcitabine single chemotherapy for biliary tract cancer patients with 5-fluorouracil refractoriness.

Sung Yong Oh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.